Clinical Trial Update: Rosiglitazone-Induced Weight Gain [NA]

View source ↗

Summary

A clinical trial evaluating Rosiglitazone-induced weight gain in patients with type 2 diabetes mellitus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Stanford University | Conditions: Diabetes Mellitus, Type 2 | NA | Status: TERMINATED